Budesonide + formoterol delivered via Spiromax® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler®.
暂无分享,去创建一个
H. Chrystyn | Y. Zöllner | A. Melani | P. Dekhuijzen | K. Kolbe | S. Torvinen | A. Plich | A. Lewis | A. Watson | M. Blackney | P N R Dekhuijzen